Compare, Analyse Suven Life Sciences with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
TEVA PHARMA
Dec-13
SUVEN LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3383,123-   
Low Rs1692,713-   
Sales per share (Unadj.) Rs52.11,792.3-  
Earnings per share (Unadj.) Rs6.8112.0-  
Cash flow per share (Unadj.) Rs8.6256.8-  
Dividends per share (Unadj.) Rs1.5098.01-  
Dividend yield (eoy) %0.63.4 17.6%  
Book value per share (Unadj.) Rs65.31,990.9-  
Shares outstanding (eoy) m127.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.6 298.8%   
Avg P/E ratio x37.126.1 142.4%  
P/CF ratio (eoy) x29.611.4 260.4%  
Price / Book Value ratio x3.91.5 265.0%  
Dividend payout %22.087.5 25.1%   
Avg Mkt Cap Rs m32,2722,474,447 1.3%   
No. of employees `0001.144.9 2.4%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.233,816.7 18.1%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.52,112.5 38.0%   
INCOME DATA
Net Sales Rs m6,6351,519,893 0.4%  
Other income Rs m2420-   
Total revenues Rs m6,8771,519,893 0.5%   
Gross profit Rs m1,604416,224 0.4%  
Depreciation Rs m221122,854 0.2%   
Interest Rs m3829,853 0.1%   
Profit before tax Rs m1,587263,516 0.6%   
Minority Interest Rs m01,197 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-172,984 0.0%   
Tax Rs m718-3,217 -22.3%   
Profit after tax Rs m86994,947 0.9%  
Gross profit margin %24.227.4 88.3%  
Effective tax rate %45.2-1.2 -3,704.7%   
Net profit margin %13.16.2 209.8%  
BALANCE SHEET DATA
Current assets Rs m6,2321,026,530 0.6%   
Current liabilities Rs m1,490895,221 0.2%   
Net working cap to sales %71.58.6 827.3%  
Current ratio x4.21.1 364.7%  
Inventory Days Days8691 95.2%  
Debtors Days Days8396 86.1%  
Net fixed assets Rs m4,043496,431 0.8%   
Share capital Rs m1273,741 3.4%   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,3101,688,313 0.5%   
Long term debt Rs m18777,155 0.0%   
Total assets Rs m10,3893,473,444 0.3%  
Interest coverage x43.19.8 438.6%   
Debt to equity ratio x00.5 0.5%  
Sales to assets ratio x0.60.4 146.0%   
Return on assets %8.73.6 243.0%  
Return on equity %10.55.6 186.0%  
Return on capital %19.54.9 395.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356242,192 0.1%  
From Investments Rs m-279-85,819 0.3%  
From Financial Activity Rs m-225-290,526 0.1%  
Net Cashflow Rs m-148-134,152 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare SUVEN LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SUVEN LIFE SCIENCES With: CIPLA  AJANTA PHARMA  SUN PHARMA  ALEMBIC PHARMA  FDC  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFE SCIENCES SHARE PRICE


Apr 16, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - ELDER PHARMA COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS